Close
Back to ACRX Stock Lookup

AcelRx Pharma (ACRX) – Major News

Nov 9, 2023 07:58 AM AcelRx Pharma (ACRX) Tops Q3 EPS by 20c
May 10, 2023 04:21 PM AcelRx Pharma (ACRX) Misses Q1 EPS by 71c
May 16, 2022 07:33 AM AcelRx Pharma (ACRX) Reports In-Line Q1 EPS
Mar 10, 2022 04:02 PM AcelRx Pharma (ACRX) Misses Q4 EPS by 6c
Nov 15, 2021 06:03 AM AcelRx Pharma (ACRX) Reports In-Line Q3 EPS
Aug 16, 2021 04:04 PM AcelRx Pharma (ACRX) Reports In-Line Q2 EPS
May 17, 2021 04:21 PM AcelRx Pharma (ACRX) Reports In-Line Q1 EPS
Mar 15, 2021 04:03 PM AcelRx Pharma (ACRX) Reports In-Line Q4 EPS, Revenues Miss
Aug 10, 2020 04:02 PM AcelRx Pharma (ACRX) Tops Q2 EPS by 6c
May 11, 2020 04:32 PM AcelRx Pharma (ACRX) Misses Q1 EPS by 3c
Nov 6, 2019 04:21 PM AcelRx Pharma (ACRX) Tops Q2 EPS by 6c
Aug 5, 2019 04:38 PM AcelRx Pharma (ACRX) Tops Q1 EPS by 6c
Mar 7, 2019 04:11 PM AcelRx Pharma (ACRX) Tops Q4 EPS by 2c
Oct 12, 2018 04:16 PM AcelRx Pharma (ACRX) Confirms FDA Advisory Committee Recommends Approval of DSUVIA for Treatment of Moderate-To-Severe Acute Pain
Oct 12, 2018 02:53 PM AcelRx Pharma's (ACRX) Pain-Killer Dsuvia Wins FDA Panel Backing, Vote 10-3 to Support Approval - Bloomberg
Aug 2, 2018 04:05 PM AcelRx Pharma (ACRX) Reports In-Line Q2 EPS
May 9, 2018 04:11 PM AcelRx Pharma (ACRX) Reports Q1 Loss of $0.23
Mar 8, 2018 04:15 PM AcelRx Pharma (ACRX) Reports In-Line Q4 EPS
Nov 9, 2017 04:02 PM AcelRx Pharma (ACRX) Misses Q3 EPS by 1c
Oct 12, 2017 06:46 AM AcelRx Pharma (ACRX) Receives CRL From FDA for DSUVIA NDA
Aug 1, 2017 07:04 AM AcelRx Pharma (ACRX) Reports Positive Device Functionality in Phase 3 Study of ZALVISO
May 8, 2017 04:02 PM AcelRx Pharma (ACRX) Misses Q1 EPS by 7c
Mar 2, 2017 04:02 PM AcelRx Pharma (ACRX) Tops Q4 EPS by 3c
Feb 27, 2017 07:02 AM AcelRx Pharma (ACRX) DSUVIA NDA Accepted; 10/12 PDUFA Date
Feb 16, 2017 04:46 PM AcelRx Pharma (ACRX) Names Vincent J. Angotti as CEO
Nov 1, 2016 04:31 PM AcelRx Pharma (ACRX) Misses Q3 EPS by 2c
Jul 28, 2016 05:48 PM AcelRx Pharma (ACRX) Misses Q2 EPS by 2c
May 2, 2016 04:05 PM AcelRx Pharma (ACRX) Misses Q1 EPS by 4c
Mar 7, 2016 04:02 PM AcelRx Pharma (ACRX) Misses Q4 EPS by 14c
Oct 29, 2015 04:05 PM AcelRx Pharma (ACRX) Posts Suprise Q3 Profit
Sep 9, 2015 06:13 AM AcelRx Pharma (ACRX) Announces ARX-04 Phase 3 Met Primary, Secondary Endpoints in Post-Surgery Pain Treatment
Aug 3, 2015 04:16 PM AcelRx Pharma (ACRX) Tops Q2 EPS by 6c
May 4, 2015 04:06 PM AcelRx Pharma (ACRX) Tops Q1 EPS by 1c; Denied Type B Meeting for Zalviso
Aug 11, 2014 04:01 PM AcelRx Pharmaceuticals (ACRX) Tops Q2 EPS by 2c
Jul 28, 2014 06:41 AM AcelRx (ACRX) Receives CRL from FDA Requesting Additional Information on Zalviso
May 8, 2014 04:06 PM AcelRx Pharmaceuticals (ACRX) Posts Q1 Loss of 22c/Share
Mar 3, 2014 04:09 PM AcelRx Pharmaceuticals (ACRX) Posts Q4 Loss of 18c/Share
Nov 5, 2013 04:16 PM AcelRx Pharmaceuticals (ACRX) Posts Q3 Loss of 26c/Share
Aug 12, 2013 04:07 PM AcelRx Pharmaceuticals (ACRX) Reports In-Line Q2 Loss of 22c/Share
Mar 12, 2013 04:23 PM AcelRx Pharmaceuticals (ACRX) Posts Q4 Loss of 41c/Share
Nov 6, 2012 04:12 PM AcelRx Pharmaceuticals (ACRX) Reports In-Line Q3 Loss of 38c/Share
Aug 9, 2012 04:07 PM AcelRx Pharmaceuticals (ACRX) Posts Q2 Loss of 35c/Share
Mar 20, 2012 07:36 AM AcelRx Pharmaceuticals (ACRX) Posts Narrower than Expected Q4 Loss of 33c/Share
Nov 8, 2011 07:33 AM AcelRx Pharmaceuticals (ACRX) Posts Q3 Loss of 30c/Share
Aug 11, 2011 07:37 AM AcelRx PHARMACEUTICALS, Inc. (ACRX) Reporsts Q2 EPS Loss of $0.26
May 12, 2011 08:11 AM AcelRx Pharma (ACRX) Posts Wider than Expected Q1 Loss
Mar 24, 2011 07:36 AM AcelRx Pharma (ACRX) Narrows Q4 Loss
Feb 11, 2011 09:08 AM AcelRx (ACRX) IPO Prices at $5, In-Line With Lowered Range

Back to ACRX Stock Lookup